CDH Proton Center commences treatment with IBA's Proteus 235 proton delivery system

IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.

“The IBA crew proved itself at our center in OKC, and consistently exceeded our expectations in Chicago. Their expertise and acumen are of great benefit.”

Working together, first in developing a center in Oklahoma City and now in suburban Chicago, IBA and ProCure have reduced the timeline for development and construction of a proton therapy center by a full year.

"This is a momentous occasion that represents a major step forward in the treatment of cancer. We are extremely proud of our partnership with ProCure and the results that it has generated." said Pierre Mottet, Chief Executive Officer of IBA. "IBA has demonstrated its continued leadership in the development of proton centers and just as we did following construction of OKC center, we look forward to making this treatment available to even more patients."

"It takes a real team effort to make this happen," said Hadley Ford, Chief Executive Officer of ProCure. "The IBA crew proved itself at our center in OKC, and consistently exceeded our expectations in Chicago. Their expertise and acumen are of great benefit."

The Chicago center is the second proton therapy installation to use inclined beam technology, which was developed by ProCure and IBA as an alternative to a gantry. The inclined beam can treat approximately 80 percent of the tumors treated with a gantry and fits in a space about half the size of a gantry room, allowing the footprint of the proton centers to be much smaller and making construction less costly. The inclined beam also requires less commissioning time and allows for easier maintenance.

Source:

Ion Beam Applications S.A. and ProCure Treatment Centers, Inc.,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Transcranial ultrasound stimulation: A new frontier in noninvasive brain therapy